Altaris completes carve-out of Clarivate’s life sciences and healthcare business
Wednesday, October 7, 2026 · first reported by PE Hub
Altaris completed acquisition of Clarivate's life sciences and healthcare business, which provides AI-enabled data intelligence and decision-support tools to pharmaceutical, biotechnology, and medical device companies.
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 source- CVC Agreed to Take a Minority Stake in Camouflage Maker Fibrotex Through Its Catalyst III FundHedgeCo Insights
- Temasek to Merge Seviora, Azalea, SeaTown Asset Management UnitsMingtiandi
- Elliott and GTCR near deal to acquire CCC Intelligent SolutionsHedgeweek +1
- Copenhagen Infrastructure Partners enters Italian biomethane market with Via Verde investmentIREI
- KGAL sells 73MW Nordic wind portfolio to Ardian-backed EnordicIPE Real Assets
- Altera's debut secondary fund sells full $27.4 million offeringSecondaryLink